The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Tadalafil-associated priapism
Abstract
A healthy 46-year-old man presented to the Emergency Department with a 36-hour history of persistent, painful erection after taking the cyclic guanylyl monophosphate-specific phosphodiesterase 5 inhibitor tadalafil. He had no other identified contributing factors for priapism. After confirmation of ischemic priapism and failure of bedside management in the Emergency Department, the patient underwent operative caverno-spongiosal shunting. Postoperatively, the erection initially rebounded but gradually receded with manual compression over 48 hours. At outpatient follow-up, the patient remained flaccid without erections. To our knowledge, this is the first report of tadalafil-associated priapism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“only a single case report exists in the literature implicating tadalafil with priapism (King et al 2005).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as King et al 2005
Citations
Cites
The efficacy and safety of tadalafil: an update
Carson, C. C., Rajfer, J., Ian Eardley, C., Carrier, S., Denne, J. S., Walker, D. J., Shen, W., & Cordell, W. H. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.04819.x · Cited by 200
Blount, M. A., Beasley, A., Zoraghi, R., Sekhar, K. R., Bessay, E. P., Francis, S. H., & Corbin, J. D. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.144 · Cited by 177
IC351 (tadalafil, Cialis): update on clinical experience
Porst, H. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900807 · Cited by 116
Nixon, R. G., O’Connor, J. L., & Milam, D. F. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000081291.37860.a5 · Cited by 79
Sildenafil citrate-Associated priapism
Sur, R. L., & Kane, C. J. (2000) · Urology · doi:10.1016/s0090-4295(99)00610-x · Cited by 59
THE EFFICACY AND SAFETY OF TADALAFIL IN UNITED STATES AND PUERTO RICAN MEN WITH ERECTILE DYSFUNCTION
Seftel, A. D., Wilson, S. K., Knapp, P. M., Shin, J., WANG, W. C., & Ahuja, S. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000132857.39680.ce · Cited by 42
Aoyagi, T., Hayakawa, K., Miyaji, K., Ishikawa, H., & Hata, M. (1999) · The Bulletin of Tokyo Dental College · doi:10.2209/tdcpublication.40.215 · Cited by 28
Cited by
Shamloul, R., & Ghanem, H. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60520-0 · Cited by 1,091
Priapism: Pathogenesis, Epidemiology, and Management
Broderick, G. A., Kadioglu, A., Bivalacqua, T. J., Ghanem, H., Nehra, A., & Shamloul, R. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01625.x · Cited by 400
Sexual dysfunction in multiple sclerosis
Kessler, T. M., Fowler, C. J., & Panicker, J. N. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.3.341 · Cited by 142
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Priapism and Sickle-Cell Anemia: Diagnosis and Nonsurgical Therapy
Broderick, G. A. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02317.x · Cited by 108
Metadata
- Authors
- King, S. H., Hallock, M., Strote, J., & Wessells, H.
- Affiliations
- University of Washington (US)
- Corresponding author
- King, Stephen H.
- Venue
- Urology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 66
- Issue
- 2
- Pages
- 432.e15-432.e18
- ISSN
- 0090-4295 (ISSN-L)
- OpenAlex
- W2026244354
- Semantic Scholar
- ade808d7c8654318058f0738c4b4e7e55bc97a25
- Cited by
- 33
- References
- 7
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2015: 1 · 2013: 1 · 2012: 4
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Urology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- tadalafil, priapism, ischemic priapism, phosphodiesterase-5 inhibitors, drug-induced priapism, erectile dysfunction, adverse drug reactions
- MeSH terms
- Tadalafil, Adult, Carbolines, Humans, Erectile Dysfunction, Male, Phosphodiesterase Inhibitors, Priapism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
